| 1 |
Doyle JJ, Neugut AI, Jacobson JS, et al. Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study [J]. J Clin Oncol, 2005, 23(34): 8597-8605.
|
| 2 |
Hooning MJ, Botma A, Aleman BMP, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer [J]. J Natl Cancer Inst, 2007, 99(5): 365-375.
|
| 3 |
Plana JC, Galderisi M, Barac A, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging [J]. Eur Heart J Cardiovasc Imaging, 2014, 15(10): 1063-1093.
|
| 4 |
Awadalla M, Mahmood SS, Groarke JD, et al. Global longitudinal strain and cardiac events in patients with immune checkpoint inhibitor-related myocarditis [J]. J Am Coll Cardiol, 2020, 75(5): 467-478.
|
| 5 |
Thavendiranathan P, Negishi T, Somerset E, et al. Strain-guided management of potentially cardiotoxic cancer therapy [J]. J Am Coll Cardiol, 2021, 77(4): 392-401.
|
| 6 |
Houbois CP, Nolan M, Somerset E, et al. Serial cardiovascular magnetic resonance strain measurements to identify cardiotoxicity in breast cancer: comparison with echocardiography [J]. JACC Cardiovasc Imaging, 2020, 14(5): 962-974.
|
| 7 |
Sonaglioni A, Albini A, Fossile E, et al. Speckle-tracking echocardiography for cardioncological evaluation in bevacizumab-treated colorectal cancer patients [J]. Cardiovasc Toxicol, 2020, 20(6): 581-592.
|
| 8 |
Foulkes S, Claessen G, Howden EJ, et al. The utility of cardiac reserve for the early detection of cancer treatment-related cardiac dysfunction: a comprehensive overview [J]. Front Cardiovasc Med, 2020, 7: 32.
|
| 9 |
Coutinho Cruz M, Moura Branco L, Portugal G, et al. Three-dimensional speckle-tracking echocardiography for the global and regional assessments of left ventricle myocardial deformation in breast cancer patients treated with anthracyclines [J]. Clin Res Cardiol, 2020, 109(6): 673-684.
|
| 10 |
Kim EK, Cho J, Kim JY, et al. Early decline in left ventricular ejection fraction can predict trastuzumab-related cardiotoxicity in patients with breast cancer: a study using 13 years of registry data [J]. Cancer Res Treat, 2019, 51(2): 727-736.
|
| 11 |
Ohtani K, Ide T, Hiasa KI, et al. Cardioprotective effect of renin-angiotensin inhibitors and β-blockers in trastuzumab-related cardiotoxicity [J]. Clin Res Cardiol, 2019, 108(10): 1128-1139.
|
| 12 |
Zamorano JL, Lancellotti P, Rodriguez Muñoz D, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines [J]. Eur Heart J, 2016, 37(36): 2768-2801.
|
| 13 |
Thavendiranathan P, Poulin F, Lim KD, et al. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review [J]. J Am Coll Cardiol, 2014, 63(25 Pt A): 2751-2768.
|
| 14 |
Negishi K, Negishi T, Hare JL, et al. Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity [J]. J Am Soc Echocardiogr, 2013, 26(5): 493-498.
|
| 15 |
Ye L, Yang ZG, Selvanayagam JB, et al. Myocardial strain imaging by echocardiography for the prediction of cardiotoxicity in chemotherapy-treated patients: a meta-analysis [J]. JACC Cardiovasc Imaging, 2020, 13(3): 881-882.
|
| 16 |
Araujo-gutierrez R, Chitturi KR, Xu J, et al. Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity [J]. Cardiooncology, 2021, 7(1): 4.
|
| 17 |
El-sherbeny WS, Sabry NM, Sharbay RM. Prediction of trastuzumab-induced cardiotoxicity in breast cancer patients receiving anthracycline-based chemotherapy [J]. J Echocardiogr, 2019, 17(2): 76-83.
|
| 18 |
Reant P, Barbot L, Touche C, et al. Evaluation of global left ventricular systolic function using three-dimensional echocardiography speckle-tracking strain parameters [J]. J Am Soc Echocardiogr, 2012, 25(1): 68-79.
|
| 19 |
Perez De Isla L, Balcones DV, Fernandez-Golfin C, et al. Three-dimensional-wall motion tracking: a new and faster tool for myocardial strain assessment: comparison with two-dimensional-wall motion tracking [J]. J Am Soc Echocardiogr, 2009, 22(4): 325-330.
|
| 20 |
Christiansen JR, Massey R, Dalen H, et al. Right ventricular function in long-term adult survivors of childhood lymphoma and acute lymphoblastic leukaemia [J]. Eur Heart J Cardiovasc Imaging, 2016, 17(7): 735-741.
|
| 21 |
Arciniegas Calle MC, Sandhu NP, Xia H, et al. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer [J]. BMC Cancer, 2018, 18(1): 1037.
|
| 22 |
Song FY, Shi J, Guo Y, et al. Assessment of biventricular systolic strain derived from the two-dimensional and three-dimensional speckle tracking echocardiography in lymphoma patients after anthracycline therapy [J]. Int J Cardiovasc Imaging, 2017, 33(6): 857-868.
|
| 23 |
Chen L, Huang J, Wu W, et al. The impact of right ventricular function on prognosis in patients with stage III non-small cell lung cancer after concurrent chemoradiotherapy [J]. Int J Cardiovasc Imaging, 2019, 35(6): 1009-1017.
|
| 24 |
Keramida K, Farmakis D, Bingcang J, et al. Longitudinal changes of right ventricular deformation mechanics during trastuzumab therapy in breast cancer patients [J]. Eur J Heart Fail, 2019, 21(4): 529-535.
|
| 25 |
Kebed KY, Addetia K, Lang RM. Importance of the left atrium [J]. Heart Failure Clinics, 2019, 15(2): 191-204.
|
| 26 |
Laufer-Perl M, Arias O, Dorfman SS, et al. Left atrial strain changes in patients with breast cancer during anthracycline therapy [J]. Int J Cardiol, 2021, 330: 238-244.
|
| 27 |
Bergamini C, Dolci G, Rossi A, et al. Left atrial volume in patients with HER2-positive breast cancer: One step further to predict trastuzumab-related cardiotoxicity [J]. Clin Cardiol, 2018, 41(3): 349-353.
|
| 28 |
Morris DA, Belyavskiy E, Aravind-Kumar R, et al. Potential usefulness and clinical relevance of adding left atrial strain to left atrial volume index in the detection of left ventricular diastolic dysfunction [J]. JACC Cardiovasc Imaging, 2018, 11(10): 1405-1415.
|
| 29 |
Buggey J, Hoit BD. Left atrial strain: measurement and clinical application [J]. Curr Opin Cardiol, 2018, 33(5): 479-485.
|
| 30 |
Anqi Y, Yu Z, Mingjun X, et al. Use of echocardiography to monitor myocardial damage during anthracycline chemotherapy [J]. Echocardiography, 2019, 36(3): 495-502.
|
| 31 |
Hochstadt A, Arnold J, Rosen R, et al. Diastolic strain time as predictor for systolic dysfunction among patients with active breast cancer [J]. Echocardiography, 2020, 37(11): 1890-1896.
|
| 32 |
Hochstadt A, Arnold J, Rosen R, et al. Longitudinal diastolic strain slope as an early sign for systolic dysfunction among patients with active cancer [J]. Clin Res Cardiol, 2020, 110(4): 569-578.
|
| 33 |
Boyd A, Stoodley P, Richards D, et al. Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study [J]. PLoS One, 2017, 12(4): e0175544.
|
| 34 |
Laufer-Perl M, Derakhshesh M, Milwidsky A, et al. Usefulness of global longitudinal strain for early identification of subclinical left ventricular dysfunction in patients with active cancer [J]. Am J Cardiol, 2018, 122(10): 1784-1789.
|
| 35 |
Thavendiranathan P, Grant AD, Negishi T, et al. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy [J]. J Am Coll Cardiol, 2013, 61(1): 77-84.
|
| 36 |
Ancedy Y, Ederhy S, Lang S, et al. Multilayer global longitudinal strain in patients with cancer: A comparison of two vendors [J]. Arch Cardiovasc Dis, 2018, 111(4): 285-296.
|